Age-related macular degeneration (AMD) is a medical condition which usually affects older adults and results in a loss of vision in the center of the visual field (the macula) because of damage to the retina. It occurs in “dry” and “wet” forms. It is a major cause of blindness and visual impairment in older adults (>50 years). Macular degeneration can make it difficult or impossible to read or recognize faces, although enough peripheral vision remains to allow other activities of daily life.
Starting from the inside of the eye and going towards the outer surface, the three main layers at the back of the eye are the retina, which is light-sensitive tissue that is considered part of the central nervous system and is actually brain tissue; the choroid, which contains the blood supply; and the sclera, which is the white, outer, layer of the eye. The macula is the central area of the retina, which provides the most detailed central vision.
Ophthalmology and Carolina Stem Cell Treatment Center
At Carolina Stem Cell Treatment Center and Cell Surgical Network, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) on various ophthalmologic conditions including Macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachments, Glaucoma, Leber’s optic neuropathy and optic neuritis. In collaboration with our opthalmology consultants we have designed protocols for visual loss conditions that emphasize safety and efficacy. The CSCTC deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement . The entire cellular surgical procedure takes approximately 3 hours.
Retinitis Pigmentosa Call to Action
We care about our Macular Degeneration patients at Carolina Stem Cell Treatment Center an affiliate of CSN. We take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the CSCTC Confidential Candidate Application, we will answer the questions and concerns you may have about CSCTC and CSN protocols for Macular Degeneration problems.